Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS

(2016) Ulrich Costabel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis

(2016) Marlies Wijsenbeek et al.   CURRENT OPINION IN PULMONARY MEDICINE

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns

(2016) Michael Kreuter et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

(2016) Carlo Albera et al.   EUROPEAN RESPIRATORY JOURNAL

Medical Therapy in Idiopathic Pulmonary Fibrosis

(2016) Wim Wuyts et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

(2016) Steven D Nathan et al.   THORAX

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume

(2016) Martin Kolb et al.   THORAX

Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients’ perspectives of the disease and treatment

(2016) Anne-Marie Russell et al.   BMC Pulmonary Medicine

Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study

(2016) Karina Raimundo et al.   BMC Pulmonary Medicine

A Clinical Study of COPD Severity Assessment by Primary Care Physicians and Their Patients Compared with Spirometry

(2015) Douglas W. Mapel et al.   AMERICAN JOURNAL OF MEDICINE

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

(2015) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers

(2015) Francesco Bonella et al.   EUROPEAN RESPIRATORY JOURNAL

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review

(2015) John Hutchinson et al.   EUROPEAN RESPIRATORY JOURNAL

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

(2015) Paul W. Noble et al.   EUROPEAN RESPIRATORY JOURNAL

The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study

(2015) Cathy Sampson et al.   BMC Pulmonary Medicine

Pulmonary Function and Survival in Idiopathic vs Secondary Usual Interstitial Pneumonia

(2014) Matthew J. Strand et al.   CHEST

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combination therapy: the future of management for idiopathic pulmonary fibrosis?

(2014) Wim A Wuyts et al.   Lancet Respiratory Medicine

Palliative Medicine and End-of-Life Care in Idiopathic Pulmonary Fibrosis

(2013) Claudia Ravaglia et al.   JOURNAL OF PALLIATIVE MEDICINE

Acute Exacerbations of Idiopathic Pulmonary Fibrosis

(2013) Katerina M. Antoniou et al.   RESPIRATION

Acute exacerbations in patients with idiopathic pulmonary fibrosis

(2013) Dong Kim   RESPIRATORY RESEARCH

Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case–control study

(2013) Vidya Navaratnam et al.   THORAX

Specialist Palliative Care is More Than Drugs: A Retrospective Study of ILD Patients

(2012) Sabrina Bajwah et al.   LUNG

‘I wish I knew more ...’ the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals: Table 1

(2012) Sabrina Bajwah et al.   BMJ Supportive & Palliative Care

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium

(2011) Steven D. Nathan et al.   CHEST

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

The rising incidence of idiopathic pulmonary fibrosis in the UK

(2011) V. Navaratnam et al.   THORAX

Living with idiopathic pulmonary fibrosis

(2011) Gadi Schoenheit et al.   Chronic Respiratory Disease

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

(2010) Brett Ley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology

(2010) C. Vancheri et al.   EUROPEAN RESPIRATORY JOURNAL

Idiopathic pulmonary fibrosis

(2008) Eric B Meltzer et al.   Orphanet Journal of Rare Diseases